The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 14, 2017
Filed:
Dec. 19, 2012
Applicant:
Allergan, Inc., Irvine, CA (US);
Inventors:
William R. Carling, Bishop's Stortford, GB;
Jose L. Martos, Basildon Essex, GB;
Jussi J. Kangasmetsa, Essex, GB;
Jenny W. Wang, Irvine, CA (US);
David F. Woodward, Lake Forest, CA (US);
Assignee:
ALLERGAN, INC., Irvine, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); C07D 231/56 (2006.01); C07D 235/08 (2006.01); C07D 401/06 (2006.01); C07D 209/08 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); C07D 209/08 (2013.01); C07D 231/56 (2013.01); C07D 235/08 (2013.01); C07D 401/06 (2013.01);
Abstract
The present invention provides a compound, that is a 1-({halo-2-[(2-hydrocarbyl or substituted hydrocarbyl)oxy]phenyl}methyl)-(fused bicyclic nitrogen heteroaryl) carboxylic acid or an ester or sulfonamide thereof. The compound may be represented by the following formula Wherein R, R, R, RA, X, W, Z and Y are as defined in the specification. The compounds may be administered to treat DP, FP, EP1, TP and/or EP4 receptor-mediated diseases or conditions.